Q177

What is the difference between peptide purity and peptide content?

Why can a peptide sample with high chromatographic purity still have a different actual peptide content, and which measurements help clarify the distinction?

General Answer

Peptide purity and peptide content answer two different questions. Purity asks: “Of everything detected in this sample, what fraction is the target peptide?” Content asks: “How much actual target peptide, by mass, is in this vial?” A sample can be 98% pure by chromatography and still contain far less than 98% peptide by weight.

Why high chromatographic purity can coexist with low peptide content:

  • Purity is relative, not absolute. HPLC or MS purity is usually an area-percent of the target peak versus other detected peaks. It says little about non-UV-active material such as water, salts, or residual solvents.
  • Counter-ions and salts. Peptides are often supplied as acetate, trifluoroacetate (TFA), or hydrochloride salts. The counter-ion mass is real mass but not peptide. A TFA salt can add a substantial percentage to the weighed powder.
  • Water and volatiles. Lyophilized powders are hygroscopic. Residual moisture (Karl Fischer) and volatile content reduce net peptide mass without creating an impurity peak.
  • Manufacturing and handling losses. Cleavage, purification, and lyophilization steps leave salts, scavengers, or moisture; vial fill weight may also vary.
  • Degradation products that co-elute. Some deamidated, oxidized, or truncated forms can be close to the main peak and may be under-reported by area-percent purity.

Measurements that clarify the distinction:

  • HPLC purity (area %) — relative purity of the target peak.
  • Mass spectrometry (ESI/LC-MS, MALDI) — confirms molecular identity and flags related impurities.
  • Karl Fischer titration — residual water content.
  • Residual solvents / TGA — volatiles and process solvents.
  • Ion chromatography or counter-ion assay — salt/counter-ion content (e.g., acetate, TFA, chloride).
  • Amino acid analysis (AAA) or nitrogen assay — estimates actual peptide mass.
  • Peptide content by UV absorbance (A280) with extinction coefficient — quantifies peptide in solution when the sequence permits.
  • Elemental analysis / ash — inorganic residue.

Practical takeaway: compare products on a “peptide content” or “net peptide” basis, not purity alone. A 10 mg vial labeled by total powder weight may contain noticeably less than 10 mg of peptide. For research buyers and clinic buyers, request a certificate of analysis that reports purity, identity, water content, counter-ion, and peptide content, and calculate dose or assay from net peptide. When sourcing across borders, buyers evaluating Chinese API or lyophilized-powder suppliers should ask for these separate measurements rather than a single purity number; our sourcing advisory can help compare suppliers on that basis.

Bottom line: purity describes how clean the target peak is; content describes how much target peptide you actually have. High purity is necessary but not sufficient — water, salts, counter-ions, and handling determine the real peptide mass in the vial.

These answers are general industry information, not regulatory, medical or legal advice. Regulatory status, import rules and clinical suitability must be verified for the specific product, jurisdiction and intended use.

Back to FAQ Knowledge Center

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.